Colchiceine | CAS#477-27-0 | anti-fibrogenic

MedKoo Cat#: 584902 | Name: Colchiceine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Colchiceine may protect rats from developing liver injury and fibrosis.

Chemical Structure

Colchiceine

CAS#477-27-0

Theoretical Analysis

MedKoo Cat#: 584902

Name: Colchiceine

CAS#: 477-27-0

Chemical Formula: C21H23NO6

Exact Mass: 385.1525

Molecular Weight: 385.42

Elemental Analysis: C, 65.44; H, 6.02; N, 3.63; O, 24.91

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Colchiceine

IUPAC/Chemical Name

Acetamide, N-(5,6,7,9-tetrahydro-10-hydroxy-1,2,3-trimethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)- (9CI)

InChi Key

PRGILOMAMBLWNG-HNNXBMFYSA-N

InChi Code

InChI=1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)/t15-/m0/s1

SMILES Code

CC(N[C@H](C1=C2)CCC3=CC(OC)=C(OC)C(OC)=C3C1=CC=C(O)C2=O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 385.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Rodríguez L, Cerbón-Ambriz J, Muñoz ML. Effects of colchicine and colchiceine in a biochemical model of liver injury and fibrosis. Arch Med Res. 1998 Summer;29(2):109-16. PubMed PMID: 9650324. 2: Edström A, Hanson M, Wallin M, Cederholm B. Inhibition of fast axonal transport and microtubule polymerization in vitro by colchicine and colchiceine. Acta Physiol Scand. 1979 Nov;107(3):233-37. PubMed PMID: 317213. 3: Hastie SB, Macdonald TL. Binding of colchiceine to tubulin. Mechanisms of ligand association with tubulin. Biochem Pharmacol. 1990 Apr 15;39(8):1271-6. PubMed PMID: 2322310. 4: Schnell E, Schönharting M, Siebert G. Metabolic transformation of colchicine, IV[1]. On the interaction of colchicine and colchiceine with sulfhydryl compounds. Hoppe Seylers Z Physiol Chem. 1976 Apr;357(4):567-71. PubMed PMID: 964916. 5: Siebert G, Schönharting M, Ott M, Surjana S. Metabolic transformation of colchicine, III. Inhibition of phosphatases by the metabolite O10-demethylcolchicine (colchiceine) and their reactivation by divalent cations. Hoppe Seylers Z Physiol Chem. 1975 Jun;356(6):855-60. PubMed PMID: 1102412. 6: Boyland E, Mawson EH. The conversion of colchicine into colchiceine. Biochem J. 1938 Jul;32(7):1204-6. PubMed PMID: 16746742; PubMed Central PMCID: PMC1264171. 7: Yagnik D, Hills F. Urate crystals induce macrophage PAF AH secretion which is differentially regulated by TGFβ1 and hydrocortisone. Mol Med Rep. 2018 Sep;18(3):3506-3512. doi: 10.3892/mmr.2018.9323. Epub 2018 Jul 26. PubMed PMID: 30066887. 8: Rösner H, Schönharting M. [Binding of colchiceine to isolated gangliosides and ganglioside-containing membranes (author's transl)]. Hoppe Seylers Z Physiol Chem. 1977 Jul;358(7):915-9. German. PubMed PMID: 892714. 9: Mourelle M, Fraginals R, Rodríguez L, Favari L, Pérez-Alvarez V. Protective effect of colchiceine against acute liver damage. Life Sci. 1989;45(10):891-900. PubMed PMID: 2571911. 10: Madsen K, Moskalewski S, Thyberg J, Friberg U. Comparison of the in vitro effects of colchicine and its derivative colchiceine on chondrocyte morphology and function. Experientia. 1979 Dec 15;35(12):1572-3. PubMed PMID: 520458. 11: Nava-Ocampo AA, Suster S, Muriel P. Effect of colchiceine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver histology in experimentally induced carbon tetrachloride cirrhosis in rats. Eur J Clin Invest. 1997 Jan;27(1):77-84. PubMed PMID: 9041381. 12: Liu HJ, Pan XX, Liu BQ, Gui X, Hu L, Jiang CY, Han Y, Fan YX, Tang YL, Liu WT. Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression. J Neuroinflammation. 2017 Apr 4;14(1):74. doi: 10.1186/s12974-017-0849-y. PubMed PMID: 28376889; PubMed Central PMCID: PMC5381065. 13: Cavazza M, Pietra F. Tautomeric selectivity towards colchicinoids in the tosylation of colchiceine on a heterogeneous, easily removable catalyst. Org Biomol Chem. 2003 Sep 7;1(17):3002-3. PubMed PMID: 14518119. 14: Dvorak Z, Ulrichova J, Pichard-Garcia L, Modriansky M, Maurel P. Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Toxicol In Vitro. 2002 Jun;16(3):219-27. PubMed PMID: 12020594. 15: Cox RJ, Al-Fahad A. Chemical mechanisms involved during the biosynthesis of tropolones. Curr Opin Chem Biol. 2013 Aug;17(4):532-6. doi: 10.1016/j.cbpa.2013.06.029. Epub 2013 Jul 16. Review. PubMed PMID: 23870699. 16: LETTRE H. [Effect of colchiceine amides on cells in vitro and in vivo]. Experientia. 1954 Jun 15;10(6):271. Undetermined Language. PubMed PMID: 13183074. 17: Shu YM, Ni RJ, Sun YJ, Fang H, Zhou JN. Distribution of corticotropin-releasing factor in the tree shrew brain. Brain Res. 2015 Aug 27;1618:270-85. doi: 10.1016/j.brainres.2015.06.004. Epub 2015 Jun 12. PubMed PMID: 26074350. 18: Bachmeyer C, Moguelet P, Rein C, Girot R. Facial lesions heralding the onset and relapse of eosinophilic fasciitis. Clin Exp Dermatol. 2016 Jun;41(4):456-7. doi: 10.1111/ced.12760. Epub 2015 Sep 7. PubMed PMID: 26344940. 19: SUNAGAWA G, NAKAMURA T, NAKAZAWA J. Studies on the total synthesis of dl-colchiceine. II. Synthesis of dl-de-methoxydeoxyhexahydrocolchiceine. Chem Pharm Bull (Tokyo). 1962 Apr;10:291-9. PubMed PMID: 13918403. 20: Bosca F, Tormos R. Behavior of drug excited states within macromolecules: binding of colchicine and derivatives to albumin. J Phys Chem B. 2013 Jun 27;117(25):7528-34. doi: 10.1021/jp402489j. Epub 2013 Jun 14. PubMed PMID: 23730875.